<DOC>
	<DOC>NCT01018186</DOC>
	<brief_summary>The purpose of this study is to evaluate the long-term safety of fluticasone furoate/GW642444</brief_summary>
	<brief_title>Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety Study</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Clinical diagnosis of asthma Reversibility FEV1 of twelve percent or greater and two hundred milliliters and greater approximately ten to forty minutes following two to four inhalations of albuterol FEV1 greater than or equal to fifty percent of predicted Currently using moderate to high dose inhaled corticosteroid therapy History of life threatening asthma Respiratory infection or oral candidiasis Asthma exacerbation Uncontrolled disease or clinical abnormality Allergies Taking another investigational medication or prohibited medication</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>